Latest Conference Articles

ACOG 2025: Joy Baker, MD, discusses the importance of listening closely to how patients describe postpartum distress—and to read between the lines.

ACOG 2025: The Junonia study was designed to understand gaps in care for women with PPD using surveys of their clinicians and care coordinators.

The nonhormonal neurokinin-3 receptor antagonist improved menopausal adiposity without appreciable impact on body weight or BMI, Santoro explained at 2025 ACOG meeting.

ACOG 2025: Pregnant patients may not want to discuss weight gain initially, so focus on overall perinatal health, and use that information to guide more conversation.

LeThenia Joy Baker, MD, explains why PPD is often overlooked compared to physical pregnancy conditions like gestational diabetes.

An intervention that included educational materials for clinicians on a multidisciplinary prenatal and postpartum care team helped drive acceptance.

Pregnant patients' perceptions do not match clinician certainty on abstinence counseling during pregnancy, and clinicians may not be asking patients about their partner's substance use.

Researchers report an alarming number of missed opportunities to screen pregnant individuals for thyroid disease, including among women with a history of the condition.

ACOG 2025: Dr Baker shares how language can help create a trusting space for patients to speak openly about postpartum depression.

ACOG 2025: Joy Baker, MD, called for stronger cross-specialty collaboration to address maternal mental health after birth.

Steven Fleischman, MD, was inaugurated as ACOG’s 76th president, urging new fellows to lead with purpose and recognize their value in women’s health care.

Fewer than half of females who experienced heavy menstrual bleeding were given hormonal treatment, and far fewer were referred to gynecology, authors reported.

The findings support the potential cardiovascular advantages of the GLP-1RA class in women with PCOS, a population already at increased cardiometabolic risk.

While exercise is beneficial during pregnancy and ACOG recommends 150 mins/week, this is the first study to examine benefits of specific regimen elements on their own.

Postmenopausal women taking fezolinetant experienced positive changes in body fat distribution, increases in which are known to increase risks of cardiometabolic disease.

Details on 12 key abstracts with clinical relevance for primary care, from menopause management to PPD screening and HPV testing.

Elinzanetant reduced VMS frequency and intensity, and improved sleep and quality of life, according to the meta-analysis to be presented at the ACOG 2025 meeting.

The two areas where primary care physicians can contribute to improving women's health, according to Laurence Shields, MD.

Building trust with patients early on will help them feel comfortable discussing their symptoms and treatment preferences, says JoAnn Pinkerton, MD.

Every patient should be offered evidence-based analgesia for pain management for in-office uterine and cervical procedures after shared, trauma-informed decision-making.

More than half of TikTok videos reviewed on hormonal birth control were patient-created and misleading while the majority of posts on endometrial cancer were by clinicians.

Two-thirds of pregnant individuals opted for either maternal vaccination against RSV or for neonatal monoclonal antibody therapy and for other vaccines recommended in pregnancy.

In a cancer survivorship clinic in urban New York, only one-quarter of long-term breast cancer survivors received genetic testing, contrary to current recommendations.

Secnidazole granules reduced recurrence rates to 20% over a period of 28 weeks in a small prospective pilot study, outperforming cumbersome daily regimens.

Medical and nonpharmacologic treatment options for VMS range in efficacy and risk/benefit profile; a short slide show offers a topline look at how many compare.

Hot flashes and night sweats are just 2 of the myriad symptoms associated with menopause. Click through a quick refresher on the transition and effective treatments.

The Teal Wand allows women to collect a vaginal sample in the privacy of their home and, according to Teal Health, the test has 96% accuracy for cervical precancer.

Rates of amputation in Black Americans with peripheral arterial disease are 3-times higher than that of their White counterparts. Dr Fakorede, discusses, here.